PHARMACYTE BIOTECH, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, new issues for the quarter ending 2023-07-31 was $0.00, a 100.00% decline year-over-year.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, new issues for the quarter ending 2022-07-31 was $880.00.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, new issues for the quarter ending 2021-10-31 was $82.61M, a 2807.01% increase year-over-year.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, new issues for the quarter ending 2020-10-31 was $2.84M, a 773.07% increase year-over-year.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, new issues for fiscal 2022 was $82.61M, a 1658.01% increase from fiscal 2021.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, new issues for fiscal 2021 was $4.70M, a 76.46% increase from fiscal 2020.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, new issues for fiscal 2020 was $2.66M, a 14.54% increase from fiscal 2019.
- PHARMACYTE BIOTECH, INC. stock issued during period, value, new issues for fiscal 2019 was $2.33M, a 13.29% decline from fiscal 2018.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-07-31 | $0.00 10-Q · filed 2023-12-15 | |
| 2022-07-31 | $880.00 10-Q · filed 2022-09-14 | |
| 2022-04-30 | $82.61M 10-K · filed 2023-07-31 | |
| 2021-10-31 | $82.61M 10-Q · filed 2023-03-16 | |
| 2021-04-30 | $4.70M 10-K · filed 2022-07-28 | |
| 2020-10-31 | $2.84M 10-Q · filed 2022-03-15 | |
| 2020-07-31 | $1.86M 10-Q · filed 2022-03-15 | |
| 2020-04-30 | $2.66M 10-K · filed 2021-08-10 | |
| 2020-01-31 | $450.00K 10-Q · filed 2020-03-13 | |
| 2019-10-31 | $325.50K 10-Q · filed 2021-03-12 | |
| 2019-07-31 | $558.00K 10-Q · filed 2021-03-12 | |
| 2019-04-30 | $2.33M 10-K · filed 2020-08-13 | |
| 2019-01-31 | $465.00K 10-Q · filed 2019-03-14 | |
| 2018-07-31 | $1.40M 10-Q · filed 2019-09-13 | |
| 2018-04-30 | $2.68M 10-K · filed 2019-08-13 | |
| 2017-07-31 | $1.75M 10-Q · filed 2019-03-14 | |
| 2016-04-30 | $3.57M 10-K · filed 2017-07-27 | |
| 2015-10-31 | $400.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2016-01-19 | $5.40M derived: sum of 4 quarters · filed 2016-07-29 |
| 2015-07-31 | $1.30M 10-Q/A · filed 2016-01-19 | $5.00M derived: sum of 4 quarters · filed 2016-07-29 |
| 2015-04-30 | $2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $3.72M 10-K · filed 2016-07-29 |
| 2015-01-31 | $848.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-13 | |
| 2014-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | |
| 2014-07-31 | $20.00K 10-Q · filed 2014-09-15 | |
| 2014-04-30 | $6.92M 10-K · filed 2016-07-29 | |
| 2013-10-31 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-16 | |
| 2013-07-31 | $1.66M 10-Q · filed 2013-09-16 | |
| 2013-04-30 | $10.00K 10-K/A · filed 2016-01-19 | |
| 2012-04-30 | $21.00K 10-K · filed 2013-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |